| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5588150 | Journal of Diabetes and its Complications | 2017 | 8 Pages |
Abstract
When given in addition to a RAS inhibitor, finerenone reduced albuminuria without adverse effects on serum potassium levels or renal function in Japanese patients with T2DM and DN.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Shigehiro Katayama, Daishiro Yamada, Mikihiro Nakayama, Takashi Yamada, Masafumi Myoishi, Masaharu Kato, Christina Nowack, Peter Kolkhof, Yoshimitsu Yamasaki, ARTS-DN Japan study group ARTS-DN Japan study group,